Position in RXST
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$509,838
-$203,771 QoQ
Shares Held
82,766
+50.8% QoQ
Ownership
0.200%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RXST Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026HRT FINANCIAL LP holds $191,091,286 across 40 Medical Devices names. RXST ranks #23 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
1,051,996 | $66,012,749 | |
| 2 | MASI |
Masimo Corp
|
264,837 | $47,106,557 | |
| 3 | BIO |
Bio-Rad Laboratories, Inc.
|
46,556 | $12,977,485 | |
| 4 | HAE |
Haemonetics Corp
|
193,634 | $10,913,212 | |
| 5 | BRKR |
Bruker Corp
|
235,704 | $8,513,628 | |
| 6 | PEN |
Penumbra Inc
|
18,854 | $6,191,087 | |
| 7 | ESTA |
Establishment Labs Holdings Inc.
|
108,802 | $6,177,777 | |
| 8 | IRMD |
Iradimed Corp
|
47,537 | $4,575,911 |
All Filings in RXST
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $509,838 | 82,766 | Shares | Defined | 2026-05-14 | |
| 2025-06-30 | $713,609 | 54,893 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,263,989 | 50,059 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,574,913 | 45,809 | Shares | Defined | 2025-02-14 | |
| 2024-06-30 | $787,865 | 13,094 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $1,838,001 | 35,634 | Shares | Defined | 2024-05-13 | |
| 2023-06-30 | $1,326,067 | 46,044 | Shares | Defined | 2023-08-11 | |
| No filing history on record for this holder in this stock. | ||||||